Cancer News and Research

Latest Cancer News and Research

Richard Axel has won the 2004 Nobel Prize in physiology or medicine

Richard Axel of the Columbia University Medical Center has won the 2004 Nobel Prize in Physiology or Medicine along with Linda B. Buck of the Fred Hutchinson Cancer Research Center for clarifying how the olfactory system works.

5 Oct 2004

Linda Buck has been named winner of the 2004 Nobel Prize in physiology or medicine

Linda Buck, Ph.D., a member of Fred Hutchinson Cancer Research Center's Basic Sciences Division, has been named winner of the 2004 Nobel Prize in physiology or medicine.

5 Oct 2004

Lack of understanding concerning Asian New Zealander health issues

The population of Asian New Zealanders is increasing faster than that of any other ethnic group in the country, yet there is still a lack of understanding concerning their health issues.

5 Oct 2004

Researchers are studying a vaccine that, in the future, could be the first to treat advanced malignant melanoma

Unlike traditional vaccines, cancer vaccines are not meant to be given to healthy people to prevent cancer. Rather, they are meant to be used in sick patients to strengthen their immune system to better fight the cancer.

4 Oct 2004

Prognostic factors influencing survival in patients with brain metastases identified

Allos Therapeutics has announced the presentation of new findings from its Phase 3 clinical trial of the investigational radiation sensitizer Efaproxyn (efaproxiral) in patients with brain metastases.

4 Oct 2004

New technique to treat condition called funnel chest, or pectus excavatum

Children and teenagers who suffer from a condition called funnel chest, or pectus excavatum, in which the chest wall becomes caved-in, now have a safe, effective and simpler surgical alternative to correct the condition, according to an article in a recent issue of the Annals of Thoracic Surgery.

4 Oct 2004

3 year study to validate bladder cancer test

A three-year study to validate a test to detect the recurrence of bladder cancer has been initiated by the National Cancer Institute (NCI), at 12 centers across the United States and Canada.

4 Oct 2004

College students may be ignoring the threat of heart disease

In a groundbreaking study, a former Arizona State University student found college students may be ignoring the threat of heart disease and putting themselves at risk.

4 Oct 2004

New statement published on nonmalignant diseases related to asbestos exposure

In its first official statement since 1986 on the topic, the American Thoracic Society (ATS) has published a document entitled “Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos.”

4 Oct 2004

Race influences participation in clinical trials

Caucasian and non-Caucasian cancer patients are equally interested in learning about clinical trials. However, non-Caucasian patients are less likely to enroll in a trial unless the chances are high that it would benefit them

4 Oct 2004

People with mental disorders develop cancer at younger ages

People with mental disorders develop cancer at younger ages and have higher odds of later being diagnosed with certain cancers, including tumors of the brain and lung, according to a new analysis of insurance claims.

4 Oct 2004

Over 170,000 Canadians took part in the largest single-day, fundraising event for breast cancer in Canada

Over 170,000 Canadians, many of them survivors, ran, walked, cheered or volunteered today as part of the largest single-day, fundraising event for breast cancer in Canada. The Run – in its 13th year – raised $19.2 million to boost breast cancer research and programs.

4 Oct 2004

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Pfizer has said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to completion.

4 Oct 2004

Artificial neural networks and DNA microarrays to successfully predict clinical outcomes of neuroblastoma patients

Researchers at the National Cancer Institute (NCI), have used artificial neural networks (ANNs) and DNA microarrays to successfully predict the clinical outcome of patients diagnosed with neuroblastoma (NB).

4 Oct 2004

New national resource for medical researchers to be known as the Center on Proteolytic Pathways

The National Institutes of Health (“NIH”) has selected The Burnham Institute to develop a national resource for medical researchers to be known as the “Center on Proteolytic Pathways”.

4 Oct 2004

Novel compound that resembles vitamin E halves the size of tumors and the ability of cancer to spread

By studying cancer in mice, researchers at The University of Texas at Austin have gained preliminary evidence that a novel compound that resembles vitamin E halves the size of tumors and the ability of cancer to spread to other body sites.

30 Sep 2004

A revolutionary approach to angiogenesis could make cancer treatment more effective at killing tumours

Dr. Olivier Feron and his team from the University of Louvain Medical School in Brussels have turned the whole concept of targeting tumour blood vessels on its head. Instead of the conventional approach of trying to starve tumour cells of the blood supply they need to grow, they are doing the opposite – opening up the tumour blood supply to allow better access for cancer drugs and more effective radiotherapy.

30 Sep 2004

Lycopene may be able to inhibit the growth of prostate tumours

A study by Dutch and German researchers has provided evidence that lycopene may be able to inhibit the growth of prostate tumours and that its effect may be enhanced if it is combined with vitamin E.

30 Sep 2004

Acne-like rash linked to effectiveness of new targeted cancer treatment – cetuximab

Acne is not a condition that anyone would welcome under normal circumstances, but an international study of a new targeted cancer treatment – cetuximab – has shown that patients who developed an acne-like rash responded better to the treatment than those who did not.

30 Sep 2004

Researchers show gossypol – a drug refined from cottonseed oil is a cancer treatment booster

New research has opened up the prospect that gossypol – a drug refined from cottonseed oil and previously tried and abandoned as a male contraceptive – could boost the effectiveness of treatment for prostate tumours and possibly other common cancers as well.

30 Sep 2004

Cancer News and Research

Latest Cancer News and Research

Richard Axel has won the 2004 Nobel Prize in physiology or medicine

Linda Buck has been named winner of the 2004 Nobel Prize in physiology or medicine

Lack of understanding concerning Asian New Zealander health issues

Researchers are studying a vaccine that, in the future, could be the first to treat advanced malignant melanoma

Prognostic factors influencing survival in patients with brain metastases identified

New technique to treat condition called funnel chest, or pectus excavatum

3 year study to validate bladder cancer test

College students may be ignoring the threat of heart disease

New statement published on nonmalignant diseases related to asbestos exposure

Race influences participation in clinical trials

People with mental disorders develop cancer at younger ages

Over 170,000 Canadians took part in the largest single-day, fundraising event for breast cancer in Canada

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Artificial neural networks and DNA microarrays to successfully predict clinical outcomes of neuroblastoma patients

New national resource for medical researchers to be known as the Center on Proteolytic Pathways

Novel compound that resembles vitamin E halves the size of tumors and the ability of cancer to spread

A revolutionary approach to angiogenesis could make cancer treatment more effective at killing tumours

Lycopene may be able to inhibit the growth of prostate tumours

Acne-like rash linked to effectiveness of new targeted cancer treatment – cetuximab

Researchers show gossypol – a drug refined from cottonseed oil is a cancer treatment booster

Cancer Research - Second Edition eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Newsletters you may be interested in